Wednesday December 10, 2014 at 11:29 AM
Richard Carvajal has been named director of Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center. (Credit: Bruce Gilbert/Columbia University)
Thursday November 13, 2014 at 3:45 PM
A 9.4 tesla MRI for imaging small animals was lifted into place at the Irving Cancer Research Center (ICRC) on Nov. 1. Installation of the MRI, a core facility for use by researchers throughout Columbia University Medical Center, is expected to be complete in 2015.
Friday November 7, 2014 at 11:39 AM
Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinicians and patients about their safety and effectiveness. In newly published guidelines from the Society for Integrative Oncology, researchers at Columbia University’s Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering, and other institutions in the U.S. and Canada, analyzed which integrative treatments appear to be most effective and safe for patients. They evaluated more than 80 different therapies.
Thursday November 6, 2014 at 3:05 PM
The National Cancer Institute (NCI) has awarded the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center a 5-year, $3.25 million Minority/Underserved Community Site grant to conduct cancer clinical trials and research on delivery of cancer care. The HICCC is the only NCI-designated Comprehensive Cancer Center to receive one of the 12 Minority/Underserved Community Site grants, which are awarded through the NCI Community Oncology Research Program (NCORP).
Monday October 13, 2014 at 4:11 PM
Annual mammograms are an important part of preventive care for all women over the age of 40. For women with a strong family history of breast cancer, it may be important to begin screenings even earlier. The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center offers cutting-edge technology and a caring staff to help make your mammogram experience both comfortable and effective. Learn more about what to expect in this video.
Monday September 8, 2014 at 7:07 PM
Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute (NCI). The grant renews the center’s status as one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
Friday August 29, 2014 at 9:44 AM
NewYork-Presbyterian/Columbia University Medical Center is finding new ways to use individualized, internal radiation delivered in the operating room immediately after a cancer tumor is removed. Intraoperative radiotherapy, or IORT, represents an effort to reduce the chance of a recurrence, shorten the duration of conventional postoperative external radiation, and reduce the risk to healthy tissue associated with external radiation.
In 2012, NewYork-Presbyterian Hospital became the first hospital in New York City to offer IORT to women with certain breast cancers. In this therapy, a spherical applicator is used to deliver a single, even dose of radiation to the inside surface of a rounded cavity after a lumpectomy.
Tuesday August 12, 2014 at 3:35 PM
Cancer has just spoken and is about to change your life with its long list of demands. The question is, “How you will you respond to it?”
Studies show this important question can best be addressed with a Palliative Care Team specially trained to help patients and their families cope with serious illness.